| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736453 | Autoimmunity Reviews | 2018 | 6 Pages |
Abstract
Our findings underscore that rheumatic iAE are part of the side effect profile of ICIs and require heightened awareness as these therapies are becoming the standard of care for various malignancies. We show that these appear later in the course of iAEs and respond preferentially to high dose steroids. MTX appears effective as a steroid sparing agent.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Merav Lidar, Eitan Giat, Daniela Garelick, Yuval Horowitz, Howard Amital, Yael Steinberg-Silman, Jacob Schachter, Ronnie Shapira-Frommer, Gal Markel,